Consistent with the cell-based in vitro studies, tumor growth of LRIG2 and LRIG2ecto overexpression groups were strikingly promoted compared to the control group (Figure 6A, B) (**P<0.01). The gene discussed is LRIG2; the disease is neoplasm.